In re 3M Bair Hugger Litig.

924 N.W.2d 16
CourtCourt of Appeals of Minnesota
DecidedJanuary 14, 2019
DocketA18-0473
StatusPublished
Cited by1 cases

This text of 924 N.W.2d 16 (In re 3M Bair Hugger Litig.) is published on Counsel Stack Legal Research, covering Court of Appeals of Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re 3M Bair Hugger Litig., 924 N.W.2d 16 (Mich. Ct. App. 2019).

Opinion

CONNOLLY, Judge

Appellants brought product-liability actions in state and federal courts, alleging that respondent's forced-air warming device (FAWD) used to maintain patients' normal body temperature during surgery increased the risk of surgical-site infection (SSI). Each party moved to exclude the *19other party's experts; appellants moved to add a claim for punitive damages; and respondent moved for summary judgment with respect to general causation. The district court granted respondent's motions and denied appellants' motions. Appellants challenge these decisions. Because we see no error in the decisions to exclude appellants' experts, to grant summary judgment to respondent, and to deny appellants' motion for punitive damages, we affirm.

FACTS

In 1987, Scott Augustine, an anesthesiologist and the CEO of Augustine Medical, Inc., invented a FAWD to maintain patients' normal body temperature during surgery. Known as the Bair Hugger, it became the leading warming device in the world. In 2002, Augustine was notified that he was under investigation for Medicare fraud. He resigned from Augustine Medical Inc., which was reorganized as Arizant Healthcare Inc. (Arizant), and Arizant retained the rights to the Bair Hugger.

In 2003, Augustine formed Augustine Biomedical + Design and invented an electric-conduction warming device (ECWD) known as the HotDog. In 2004, he pleaded guilty to Medicare fraud, was fined $2 million, and was prohibited from participating in federal health-care programs for five years.

During those years, he deprecated the Bair Hugger in other countries, leading the UK National Institute for Health and Clinical Excellence to reject his claim that FAWDs increase the risk of SSI and a German court to enjoin him from making false claims that the Bair Hugger increased bacterial contamination in operating rooms.

In 2009, Augustine hired a law firm to promote the use of his ECWD and agreed to work with the law firm as a nontestifying expert for individuals who brought lawsuits against Arizant. The U.S. Food and Drug Administration (FDA) investigated Augustine's claims that the Bair Hugger increased the risk of bacterial contamination and rejected them.

In 2010, Arizant was acquired by respondent 3M Company (3M). Augustine repeatedly and unsuccessfully attempted to induce 3M to purchase the HotDog system, which he claimed reduced the rate of SSI compared to FAWDs such as the Bair Hugger. The FDA warned Augustine that his claim lacked clinical support.

In 2013, the law firm that Augustine had hired began filing lawsuits against Arizant and 3M, claiming that the Bair Hugger was unsafe. In 2014, Augustine funded the McGovern Study,1 which purported to find an association between the Bair Hugger and increased SSIs. One of the study's authors, a former employee of Augustine, testified that "[t]he study does not establish a causal basis" and characterized it as marketing rather than research.

In 2017, the FDA sent a Safety Alert to healthcare providers "reminding [them] that using thermoregulation devices during surgery, including [FAWDs], ha[s] been demonstrated to result in less bleeding, faster recovery times, and decreased risk of infection for patients"; advising them that "[a]fter a thorough review of available data, [the FDA was] unable to identify a consistently reported association between the use of [FAWDs] and [SSIs]"; and recommending "the use of thermoregulating devices (including [FAWDs] ) for surgical procedures."

*20To support the claims in their lawsuits, appellants retained three general-causation2 medical experts, none of whom had previously studied the efficacy of FAWDs or published peer-reviewed articles relevant to the claims in this litigation and none of whom claimed that their general-causation opinions were generally accepted within the relevant scientific community. On respondent's motion, the district court excluded the testimony of appellants' experts and consequently granted respondent summary judgment with respect to general causation. The district court also denied appellants' motion to amend their complaint by adding a claim for punitive damages. Appellants challenge these decisions.

ISSUES

1. Did the district court err in applying Minn. R. Evid. 702 to exclude appellants' experts' opinions?

2. Did the district court err in denying appellants' motion to amend their complaint to add a claim for punitive damages?

ANALYSIS

1. Minn. R. Evid. 702

We start from the basic premise that we are a Frye - Mack state. Doe v. Archdiocese of Saint Paul and Minneapolis , 817 N.W.2d 150, 156 (Minn. 2012) ("The Frye -Mack standard governs the admissibility of expert testimony that involves a novel scientific theory.") (quotation omitted); Goeb v. Tharaldson , 615 N.W.2d 800, 814 (Minn. 2000) (reaffirming Minnesota's adherence to the Frye -Mack general-acceptance standard and rejecting the less-stringent standard set out in Daubert v. Merrell Dow Pharms., Inc ., 509 U.S. 579, 589-90, 113 S.Ct. 2786, 2794-95, 125 L.Ed.2d 469 (1993) ).3 Consequently, "if the [expert's] opinion or evidence involves novel scientific theory, the proponent must establish that the underlying scientific evidence is generally accepted in the relevant scientific community." Minn. R. Evid. 702 (codifying the Frye -Mack test). The district court concluded that "[appellants] have failed to satisfy the general-acceptance standard under [ Minn. R. Evid. 702 ] and, consequently, their experts' general-causation opinions are inadmissible." This court reviews de novo a decision as to whether underlying scientific evidence is generally accepted in the relevant scientific community. Goeb , 615 N.W.2d at 814.

Appellants argue first that the general-acceptance test is not relevant because "the science used here was not 'novel' " within the meaning of Minn. R. Evid. 702. See State v.Roman Nose , 649 N.W.2d 815, 821 (Minn. 2002) (noting that a scientific technique is novel until "[a] court has reviewed and confirmed [its] general acceptance"). But Minn. R. Evid.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
924 N.W.2d 16, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-3m-bair-hugger-litig-minnctapp-2019.